SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

2.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

3.

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

4.

As pesticides and wildfires rise, kids with cancer need resources

5.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot